1887

Journal of General Virology header logo

Volume 86, Issue 1

Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1 and 18 Free

Abstract

Several NS1 mutant viruses of human influenza A/PR/8/34 (H1N1) virus were tested for their ability to induce pro-inflammatory cytokines in primary human macrophages. The findings revealed a pronounced difference in the virus-induced cytokine pattern, depending on the functionality of the NS1 protein-encoded domains. The PR8/NS1–125 mutant virus, which encodes the first 125 aa of the NS1 protein, thus lacking the C-terminal domains, induced significantly higher amounts of beta interferon, interleukin (IL) 6, tumour necrosis factor alpha and CCL3 (MIP-1) when compared with the A/PR/8/34 wild-type virus. However, this mutant virus was as efficient as wild-type virus in the inhibition of IL1 and IL18 release from infected macrophages. Another group of viral mutants either lacking or possessing non-functional RNA-binding and dimerization domains induced 10–50 times more biologically active IL1 and five times more biologically active IL18 than the wild-type or PR8/NS1–125 viruses. The hallmark of infection with this group of mutant viruses was the induction of rapid apoptosis in infected macrophages, which correlated with the enhanced activity of caspase-1. These results indicated that the NS1 protein, through the function of its N-terminal domains, might control caspase-1 activation, thus repressing the maturation of pro-IL1-, pro-IL18- and caspase-1-dependent apoptosis in infected primary human macrophages.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80422-0
2005-01-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/1/vir860185.html?itemId=/content/journal/jgv/10.1099/vir.0.80422-0&mimeType=html&fmt=ahah

References

  1. Adachi M., Matsukura S., Tokunaga H., Kokubu F. 1997; Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int Arch Allergy Immunol 113:307–311 [CrossRef]
     [Google Scholar]
  2. Adcock I. M. 1997; Transcription factors as activators of gene transcription: AP-1 and NF- κ B. Monaldi Arch Chest Dis 52:178–186
     [Google Scholar]
  3. Balachandran S., Kim C. N., Yeh W.-C., Mak T. W., Bhalla K., Barber G. N. 1998; Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17:6888–6902 [CrossRef]
     [Google Scholar]
  4. Balachandran S., Roberts P. C., Kipperman T., Bhalla K. N., Compans R. W., Archer D. R., Barber G. N. 2000; Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J Virol 74:1513–1523 [CrossRef]
     [Google Scholar]
  5. Barnes B., Lubyova B., Pitha P. M. 2002; On the role of IRF in host defense. J Interferon Cytokine Res 22:59–71 [CrossRef]
     [Google Scholar]
  6. Bergmann M., Garcia-Sastre A., Carnero E., Pehamberger H., Wolff K., Palese P., Muster T. 2000; Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6206 [CrossRef]
     [Google Scholar]
  7. Bradney C. P., Sempowski G. D., Liao H.-X., Haynes B. F., Staats H. F. 2002; Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization. J Virol 76:517–524 [CrossRef]
     [Google Scholar]
  8. Castelli J. C., Hassel B. A., Maran A., Paranjape J., Hewitt J. A., Li X., Hsu Y.-T., Silverman R. H., Youle R. J. 1998; The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ 5:313–320 [CrossRef]
     [Google Scholar]
  9. Chen Z., Li Y., Krug R. M. 1999; Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J 18:2273–2283 [CrossRef]
     [Google Scholar]
  10. Chen W., Calvo P. A., Malide D. 10 other authors 2001; A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312 [CrossRef]
     [Google Scholar]
  11. Cohen G. M. 1997; Caspases: the executioners of apoptosis. Biochem J 326:1–16
     [Google Scholar]
  12. de la Luna S., Fortes P., Beloso A., Ortín J. 1995; Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol 69:2427–2433
     [Google Scholar]
  13. Egorov A., Brandt S., Sereinig S. 7 other authors 1998; Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72:6437–6441
     [Google Scholar]
  14. García-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T. 1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330 [CrossRef]
     [Google Scholar]
  15. Ghayur T., Banerjee S., Hugunin M. 11 other authors 1997; Caspase-1 processes IFN- γ -inducing factor and regulates LPS-induced IFN- γ production. Nature 386:619–623 [CrossRef]
     [Google Scholar]
  16. Gu Y., Kuida K., Tsutsui H. 14 other authors 1997; Activation of interferon- γ inducing factor mediated by interleukin-1 β converting enzyme. Science 275:206–209 [CrossRef]
     [Google Scholar]
  17. Hanada T., Yoshimura A. 2002; Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 13:413–421 [CrossRef]
     [Google Scholar]
  18. Hatada E., Saito S., Fukuda R. 1999; Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73:2425–2433
     [Google Scholar]
  19. Iordanov M. S., Wong J., Bell J. C., Magun B. E. 2001; Activation of NF- κ B by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol Cell Biol 21:61–72 [CrossRef]
     [Google Scholar]
  20. Jacobs B. L., Langland J. O. 1996; When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339–349 [CrossRef]
     [Google Scholar]
  21. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melén K., Matikainen S. 2001; Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12:171–180 [CrossRef]
     [Google Scholar]
  22. Kaufmann A., Salentin R., Meyer R. G. 7 other authors 2001; Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 204:603–613 [CrossRef]
     [Google Scholar]
  23. Kim M.-J., Latham A. G., Krug R. M. 2002; Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 99:10096–10101 [CrossRef]
     [Google Scholar]
  24. Kittel C., Sereinig S., Ferko B., Stasakova J., Romanova J., Wolkerstorfer A., Katinger H., Egorov A. 2004; Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324:67–73 [CrossRef]
     [Google Scholar]
  25. Kozak W., Zheng H., Conn C. A., Soszynski D., van der Ploeg L. H., Kluger M. J. 1995; Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 β -deficient mice. Am J Physiol 269:R969–R977
     [Google Scholar]
  26. Krug R. M., Yuan W., Noah D. L., Latham A. G. 2003; Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181–189 [CrossRef]
     [Google Scholar]
  27. Li P., Allen H., Banerjee S. 14 other authors 1995; Mice deficient in IL-1 β -converting enzyme are defective in production of mature IL-1 β and resistant to endotoxic shock. Cell 80:401–411 [CrossRef]
     [Google Scholar]
  28. Lisowska K., Witkowski J. M. 2003; Viral strategies in modulation of NF- κ B activity. Arch Immunol Ther Exp (Warsz 51:367–375
     [Google Scholar]
  29. Liu B., Mori I., Hossain M. J., Dong L., Takeda K., Kimura Y. 2004; Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85:423–428 [CrossRef]
     [Google Scholar]
  30. Lu Y., Wambach M., Katze M. G., Krug R. M. 1995; Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222–228 [CrossRef]
     [Google Scholar]
  31. Maniatis T., Falvo J. V., Kim T. H., Kim T. K., Lin C. H., Parekh B. S., Wathelet M. G. 1998; Structure and function of the interferon- β enhanceosome. Cold Spring Harbor Symp Quant Biol 63:609–620 [CrossRef]
     [Google Scholar]
  32. Matikainen S., Pirhonen J., Miettinen M., Lehtonen A., Govenius-Vintola C., Sareneva T., Julkunen I. 2000; Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 276:138–147 [CrossRef]
     [Google Scholar]
  33. Matsukura S., Kokubu F., Noda H., Tokunaga H., Adachi M. 1996; Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 98:1080–1087 [CrossRef]
     [Google Scholar]
  34. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. 2001; Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:53–72 [CrossRef]
     [Google Scholar]
  35. Noah D. L., Twu K. Y., Krug R. M. 2003; Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395 [CrossRef]
     [Google Scholar]
  36. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., Matikainen S. 1999; Virus infection activates IL-1 β and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 162:7322–7329
     [Google Scholar]
  37. Pirhonen J., Sareneva T., Julkunen I., Matikainen S. 2001; Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur J Immunol 31:726–733 [CrossRef]
     [Google Scholar]
  38. Sareneva T., Matikainen S., Kurimoto M., Julkunen I. 1998; Influenza A virus-induced IFN- α / β and IL-18 synergistically enhance IFN- γ gene expression in human T cells. J Immunol 160:6032–6038
     [Google Scholar]
  39. Servant M. J., Grandvaux N., Hiscott J. 2002; Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 64:985–992 [CrossRef]
     [Google Scholar]
  40. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E. S. 1996; Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci U S A 93:14486–14491 [CrossRef]
     [Google Scholar]
  41. Staats H. F., Bradney C. P., Gwinn W. M., Jackson S. S., Sempowski G. D., Liao H.-X., Letvin N. L., Haynes B. F. 2001; Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J Immunol 167:5386–5394 [CrossRef]
     [Google Scholar]
  42. Takizawa T., Fukuda R., Miyawaki T., Ohashi K., Nakanishi Y. 1995; Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology 209:288–296 [CrossRef]
     [Google Scholar]
  43. Takizawa T., Ohashi K., Nakanishi Y. 1996; Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol 70:8128–8132
     [Google Scholar]
  44. Takizawa T., Tatematsu C., Ohashi K., Nakanishi Y. 1999; Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol Immunol 43:245–252 [CrossRef]
     [Google Scholar]
  45. Talon J., Horvath C. M., Polley R., Basler C. F., Muster T., Palese P., García-Sastre A. 2000; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996 [CrossRef]
     [Google Scholar]
  46. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A. A., García-Sastre A. 2000; Influenza A virus NS1 protein prevents activation of NF- κ B and induction of alpha/beta interferon. J Virol 74:11566–11573 [CrossRef]
     [Google Scholar]
  47. Wurzer W. J., Planz O., Ehrhardt C., Giner M., Silberzahn T., Pleschka S., Ludwig S. 2003; Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22:2717–2728 [CrossRef]
     [Google Scholar]
  48. Zhirnov O. P., Konakova T. E., Garten W., Klenk H.-D. 1999; Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol 73:10158–10163
     [Google Scholar]
  49. Zhirnov O. P., Konakova T. E., Wolff T., Klenk H.-D. 2002; NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76:1617–1625 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80422-0
Loading
Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18
J. Gen. Virol. 86, 185 (2005); https://doi.org/10.1099/vir.0.80422-0
/content/journal/jgv/10.1099/vir.0.80422-0
/content/journal/jgv/10.1099/vir.0.80422-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error